Investing Profile

Cindy Xiong

InvestorVC
Partner at Venrock
Photo of Cindy Xiong, Partner at Venrock

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Michigan Network
275 CONNECTIONS
Vidazoo by Perion Network
59 CONNECTIONS
Vidazoo by Perion Network
59 CONNECTIONS
Vidazoo by Perion Network
59 CONNECTIONS
Venrock Network
47 CONNECTIONS
cb
Venrock Partner
$100K - $5.0M
$1.5M
3
$450M
CompanyStageDateRound SizeTotal Raised
Pinnacle Medicines
Series BMar 2026$89M
$89M
Slate Medicines
Series AFeb 2026$130M
$130M
Co-investors: Andrew Levin (RA Capital Management)
ImmPACT Bio
Series BJan 2022$140M
$140M
Co-investors: Yvonne Yamanaka (venBio Partners), Richard Gaster (venBio Partners), Jim Tananbaum (Foresite Capital Management)
Scientist Agenovir CorporationPresent
Scientist AgenovirPresent
Summer Analyst Vidazoo by PerionPresent
Summer Analyst Tybourne Capital ManagementPresent
MBA Intern Lilly Asia VenturesPresent
Board Observer Kriya TherapeuticsPresent
Board Observer Kriya Therapeutics, Inc.Present
Board Observer Remix TherapeuticsPresent
Board Observer XinThera Inc.Present
Board Member ImmPACT BioPresent
Board Observer RayTheraPresent
Board Observer Vidazoo by PerionPresent
Board Member Chimagen BiosciencesPresent
Board Member Vidazoo by PerionPresent
Board Member Slate MedicinesPresent
Board Observer Pinnacle MedicinesPresent
Partner Foresite CapitalPresent
Partner VenrockPresent
Shanghai Jiao Tong University Bachelor's degree Bachelor's degree, Biotechnology and Bioengineering
Shanghai Jiao Tong University Bachelor's degree Biotechnology and Bioengineering
University of Michigan Doctor of Philosophy (PhD) Molecular, Cellular and Developmental Biology
Sign in with Google →
Sign in with Google →